3D Global Biotech Inc. (TPEX:6808)
Taiwan · Delayed Price · Currency is TWD 40.00
-0.15 (-0.37%)
Jul 30, 2026, 2:00 PM CST
3D Global Biotech Market Cap
3D Global Biotech has a market cap or net worth of 3.09 billion as of July 29, 2026. Its market cap has decreased by -17.10% in one year.
Market Cap
3.09B
Enterprise Value
2.66B
Revenue
206.74M
Ranking
n/a
PE Ratio
47.80
Stock Price
40.00
ChartMarket Cap Chart
Since December 25, 2020, 3D Global Biotech's market cap has increased from 2.74B to 3.09B, an increase of 12.96%. That is a compound annual growth rate of 2.20%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 30, 2026 | 3.09B | -17.79% |
| Dec 31, 2025 | 3.76B | -26.72% |
| Dec 31, 2024 | 5.13B | 371.49% |
| Dec 29, 2023 | 1.09B | -27.35% |
| Dec 30, 2022 | 1.50B | -30.09% |
| Dec 30, 2021 | 2.14B | -18.98% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 25, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Senhwa Biosciences | 3.52B |
| OBI Pharma | 3.46B |
| BioGend Therapeutics | 3.27B |
| Great Novel Therapeutics Biotech & Medicals | 3.23B |
| Sagittarius Life Science | 3.21B |
| SYN-TECH Chem. & Pharm. | 3.20B |
| Apex Biotechnology | 3.17B |
| Shine-On BioMedical | 3.14B |